Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years

Lu,Xiaoxu; Wu,Hui; Wang,Jianhua; Xu,Jing

doi:10.3892/mco.2013.235

March-April 2014 Volume 2 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-April 2014 Volume 2 Issue 2

Full Size Image

Article

Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years

Authors:
- Xiaoxu Lu
- Hui Wu
- Jianhua Wang
- Jing Xu
View Affiliations / Copyright

Affiliations: Department of Radiotherapy, Affiliated Tumor Hospital of Zhengzhou University, Henan Tumor Hospital, Jinshui, Henan 45003, P.R. China
Pages: 297-301
|
Published online on: December 31, 2013

https://doi.org/10.3892/mco.2013.235
Expand metrics +

Abstract

The most relevant treatment modalities in elderly patients with esophageal carcinoma (EC) remain a subject of debate. Combined definitive chemoradiotherapy (CRT) is currently widely accepted as a non‑surgical treatment for esophageal cancer. However, elderly patients were excluded from the majority of studies on CRT, or the proportion of elderly patients was relatively low in those studies and the number of available studies on the treatment of EC patients aged ≥75 years is limited. The aim of the present retrospective study was to analyze the safety and efficacy of CRT in patients aged ≥75 years in order to assess the short‑ and long‑term outcomes of CRT for elderly patients with EC. In this study, based on further refinement of patient age groups and analysis of the Charlson comorbidity score, we performed a statistical analysis of factors such as short‑term response, long‑term survival and toxicity reactions. The results of the analysis indicated that the treatment of patients with EC aged ≥75 years with radiotherapy (RT) and chemotherapy was effective. However, we recommend that customized treatment is based on the stratification of patients into different age groups and the Charlson score, as for patients aged ≥80 years a lower‑dose therapy may be more beneficial and for patients aged ≥85 years definitive CRT should be administered with greater caution.

View Figures

View References

1	Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 281:1623–1627. 1999. View Article : Google Scholar : PubMed/NCBI
2	Minsky BD, Pajak TF, Ginsberg RJ, et al: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 20:1167–1174. 2002. View Article : Google Scholar : PubMed/NCBI
3	Steyerberg EW, Neville B, Weeks JC and Earle CC: Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 25:2389–2396. 2007. View Article : Google Scholar : PubMed/NCBI
4	Ruol A, Portale G, Zaninotto G, et al: Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg. 133:1186–1192. 2007. View Article : Google Scholar : PubMed/NCBI
5	Kleinberg L and Forastiere AA: Chemoradiation in the management of esophageal cancer. J Clin Oncol. 25:4110–4117. 2007. View Article : Google Scholar : PubMed/NCBI
6	Kosugi S, Sasamoto R, Kanda T, Matsuki A and Hatakeyama K: Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older. Jpn J Clin Oncol. 39:360–366. 2009.PubMed/NCBI
7	Tougeron D, Di Fiore F, Thureau S, et al: Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer. 99:1586–1592. 2008. View Article : Google Scholar : PubMed/NCBI
8	Klabunde CN, Potosky AL, Legler JM and Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol. 53:1258–1267. 2000. View Article : Google Scholar : PubMed/NCBI
9	Therase P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines). J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar
10	Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
11	Trotti A, Byhardt R, Stetz J, et al: Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:13–47. 2000. View Article : Google Scholar : PubMed/NCBI
12	Arias E: United States life tables, 2006. Natl Vital Stat Rep. 58:1–40. 2010.
13	Anderson SE, Minsky BD, Bains M, Hummer A, Kelsen D and Ilson DH: Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer. 96:1823–1827. 2007. View Article : Google Scholar : PubMed/NCBI
14	Popescu RA, Norman A, Ross PJ, Parikh B and Cunningham D: Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol. 17:2412–2418. 1999.PubMed/NCBI
15	Trumper M, Ross PJ, Cunningham D, et al: Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: a pooled analysis of three clinical trials. Eur J Cancer. 42:827–834. 2006. View Article : Google Scholar : PubMed/NCBI
16	Tougeron D, Hamidou J, Scotté M, Di Fiore F, Antonietti M, Paillot B and Michel P: Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 10:5102010. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years

This article is mentioned in:

Abstract

Related Articles